Analytical methods for the quantitative determination of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in biological samples
- 15 August 2003
- journal article
- review article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 793 (2), 193-205
- https://doi.org/10.1016/s1570-0232(03)00314-3
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Trends in the Incidence of Myocardial Infarction and in Mortality Due to Coronary Heart Disease, 1987 to 1994New England Journal of Medicine, 1998
- Mortality by cause for eight regions of the world: Global Burden of Disease StudyThe Lancet, 1997
- Hyperlipidemia and Coronary DiseaseCirculation, 1995
- The Response-to-Retention Hypothesis of Early AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Mapping and geographic display of dataStatistics in Medicine, 1995
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995
- NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart DiseasePublished by American Medical Association (AMA) ,1993
- Cholesterol and mortality. 30 years of follow-up from the Framingham studyJAMA, 1987
- Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart DiseaseAnnals of Internal Medicine, 1971
- Prediction of Coronary Heart Disease Based on Clinical Suspicion, Age, Total Cholesterol, and TriglycerideCirculation, 1970